@prowiz
Aegros is progressing nicely
In my opinion there's more than 99% CSL buy into Aegros before IPO
CSL stand to lose the most if Aegros succeeds as a plasma competitor or benefit the most from acquiring Aegros prior to IPO
Aegros & CSL are both presenting at upcoming July Protein conference in Brisbane
to think CSL isn't very interested in Aegros as a significant competitor or shrewd acquisition seems far fetched
It's possible that international fractionators are willing to pay massive premium to acquire Aegros - CSL can potentially dominate global plasma markets if it acquires Aegros - or waste an opportunity & risk the rise of Aegros plasma technology
interesting times ahead & can't see CSL allowing Aegros to fall into foreign hands or influence
@prowizAegros is progressing nicelyIn my opinion there's more...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$311.70 |
Change
0.580(0.19%) |
Mkt cap ! $150.6B | |||
| Open | High | Low | Value | Volume |
| $308.37 | $311.70 | $307.33 | $411.6M | 1.374M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55 | $310.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $311.74 | 904 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |